Performance eradication of Staphylococcus aureus with mupirocin in nasal personnel ICU ward.
Phase 2
- Conditions
- Staphylococcus aureus infection.Staphylococcus aureus as the cause of diseases classified to other chapters
- Registration Number
- IRCT2014102519666N1
- Lead Sponsor
- Vice Chancellor for Research and Technology, Golestan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
patients suffering from hospital infection with MRSA Staphylococcus aureus infection.
Exclusion criteria: patients with kidney disease; dialysis; pregnancy and also sensitivity to drug.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Staphylococcus aureus. Timepoint: 3 month before and 3 month after intervention. Method of measurement: one coloni in culture & PCR.
- Secondary Outcome Measures
Name Time Method